Personalizing biomarker strategies in heart failure with galectin-3

Author： Sherwi Nasser   Merali Shermin   Wong Kenneth  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.8, Iss.6, 2012-11, pp. : 885-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 5, 2016-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

GDF 15 - A Novel Biomarker in the Offing for Heart Failure

By  

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-02 ,pp. : 37-46

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarker guided therapy for heart failure: focus on natriuretic peptides

By Adams Kirkwood   Felker G.   Fraij Ghassan   Patterson J.   O’Connor Christopher  

Heart Failure Reviews, Vol. 15, Iss. 4, 2010-07 ,pp. : 351-370

Springer Publishing Company

Access to resources Recommend Favorite

Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence

By  

Current Cardiology Reviews, Vol. 11, Iss. 1, 2015-02 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence

By  

Current Cardiology Reviews, Vol. 11, Iss. 1, 2014-11 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite